Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/AVACTA-GROUP-PLC-26123500/noticia/Avacta-dosifica-al-tercer-paciente-del-ensayo-de-conjugado-de-f-rmaco-para-tejido-tumoral-46251188/?utm_source=whatsapp&utm_medium=social&utm_campaign=share